PDT Partners’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

PDT Partners’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-3,427	Closed	-$120K	–	554
2018 Q2	$120K	Sell	3,427 -15,533	-82%	-$596K	﹤0.01%	495
2018 Q1	$882K	Buy	18,960 +8,971	+90%	+$328K	0.03%	367
2017 Q4	$375K	Sell	9,989 -103	-1%	-$4.5K	0.01%	465
2017 Q3	$537K	Buy	10,092 +92	+0.9%	+$5.47K	0.02%	424
2017 Q2	$570K	Buy	+10,000	New	+$502K	0.02%	393
2017 Q1	–	Sell	-6,532	Closed	-$372K	–	545
2016 Q4	$372K	Sell	6,532 -4,521	-41%	-$273K	0.02%	423
2016 Q3	$687K	Hold	11,053	–	–	0.04%	345
2016 Q2	$625K	Buy	11,053 +3,780	+52%	+$230K	0.05%	306
2016 Q1	$466K	Buy	7,273 +2,160	+42%	+$175K	0.03%	421
2015 Q4	$719K	Buy	+5,113	New	+$694K	0.1%	243

Other funds holding KDNY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

HMC

Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return

PDT Partners's KDNY Position: Q3 2018 in Review

PDT Partners sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2018, closing a stake of 3,427 shares — an estimated $120K sold.

PDT Partners first reported a position in KDNY in Q4 2015 and held it in 10 quarters. The position peaked at $882K in Q1 2018. 87 funds tracked by Wall St. Rank hold KDNY as of Q3 2018.

PDT Partners reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
PDT Partners sold 3,427 Chinook Therapeutics, Inc. Common Stock shares in Q3 2018, an estimated $120K.
PDT Partners first reported a position in Chinook Therapeutics, Inc. Common Stock in Q4 2015 and held it in 10 quarters.
PDT Partners's Chinook Therapeutics, Inc. Common Stock position peaked at $882K in Q1 2018.
87 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2018.

Based on PDT Partners's 13F filing for Q3 2018, filed 14 Nov 2018.